CONNECT Intervention for Lung Cancer Screening
(CONNECT-ML Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist Spanish and Cantonese-speaking smokers in quitting smoking during lung cancer screening. It tests the CONNECT Intervention for multilingual populations, a personalized program featuring interactive video sessions with a virtual doctor, supportive text messages, phone calls, and access to a pharmacist for nicotine replacement medications. Participants include California residents who smoke and qualify for lung cancer screening. The trial will collect feedback from participants to refine the program and assess its effectiveness. As an unphased trial, this study provides participants the chance to contribute to innovative research that could improve smoking cessation support for diverse communities.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It focuses on smoking cessation support, so it's best to discuss your medications with the trial team or your doctor.
What prior data suggests that the CONNECT Intervention for multilingual populations is safe?
Studies have shown that participants generally find the CONNECT program easy to handle. This program helps people quit smoking by offering personalized support through videos, text messages, and phone calls. Participants can also consult a pharmacist about using nicotine replacement therapy, a common method to aid smoking cessation.
No major reports of negative effects have been linked to the CONNECT program. Since it focuses on providing support rather than introducing a new drug or medical device, it is considered safe. The CONNECT program has undergone testing, and its methods have proven safe and effective in helping people quit smoking.12345Why are researchers excited about this trial?
The CONNECT intervention for lung cancer screening is unique because it offers a multilingual approach to smoking cessation, which is not typically found in standard treatments like nicotine replacement therapy or prescription medications such as varenicline and bupropion. Researchers are excited about this trial because it includes an innovative blend of interactive video interventions, weekly text messages, and personalized counseling calls, all tailored to different languages. This approach not only makes quitting smoking more accessible to diverse populations but also integrates direct pharmacist support, potentially increasing the effectiveness of quitting efforts and addressing a wider range of smoking cessation barriers.
What evidence suggests that the CONNECT Intervention for multilingual populations could be effective for smoking cessation?
Research has shown that personalized programs like the CONNECT program, which participants in this trial may receive, can help people quit smoking. Studies have found that a combination of text messages, video support, and assistance from pharmacists increases the chances of quitting. The CONNECT program, part of this trial's lung cancer screening intervention, includes these tools to assist smokers who want to stop. Early results suggest that tailoring support to each person's needs enhances effectiveness. Additionally, reaching out to communities that speak different languages makes the program more effective by increasing accessibility.12356
Who Is on the Research Team?
Judith Walsh, MD, MPH
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for adult smokers in Spanish and Cantonese speaking communities who are participating in lung cancer screening. It's designed to help them quit smoking using the CONNECT Multilingual program, which includes a video doctor, messaging support, and pharmacist assistance for nicotine replacement.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Focus Group
Participants in the focus group will be interviewed by the study staff and discuss barriers and facilitators to smoking cessation
Beta Testing
Participants will be testing the CONNECT multilingual smoking cessation materials and provide feedback to investigators
Randomized Controlled Trial
Participants receive either the CONNECT Multilingual intervention or usual care, followed up at 1-week, 1-, 3-, and 6-months
Follow-up
Participants are monitored for smoking cessation rates and utilization of resources
What Are the Treatments Tested in This Trial?
Interventions
- CONNECT Intervention for multilingual populations
Trial Overview
The study tests the effectiveness of the CONNECT ML program in aiding smoking cessation among multilingual populations. Participants will receive personalized support through videos, texts, calls, and pharmacy services as part of their lung cancer screening process.
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Active Control
Participants will receive usual care for smoking cessation at routine medical visit and be asked to complete a total of four brief follow-up phone surveys. Participants will be asked to provide a saliva sample at the end of the study.
Participants receive the CONNECT multilingual smoking cessation intervention finalized in the beta group analysis, that includes multi-lingual interactive video doctor intervention, text messages once weekly for 12 weeks, and several telephone counseling calls. Participants also receive access to a pharmacist to receive counseling about quitting smoking and may prescribe nicotine replacement therapy. Participants will be asked to provide a saliva sample at the end of the study
Participants in the focus group will be interviewed by the study staff and discuss barriers and facilitators to smoking cessation to be implemented in the beta and randomized phases of the study.
Participants will be testing the CONNECT multilingual smoking cessation materials and provide feedback to investigators. Participation will be limited to about 1.5 - 2 hours.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
Tobacco Related Disease Research Program
Collaborator
Citations
Evaluating the Impact of CONNECT in a Multilingual ...
The CONNECT program encourages individuals who are undergoing lung cancer screening to also quit smoking by providing a personalized program which includes a ...
CONNECT in a Multilingual Population
This clinical trial will develop and ultimately test how well the CONNECT Multilingual (CONNECT ML) program works to improve smoking cessation ...
CONNECT Intervention for Lung Cancer Screening ...
This clinical trial will develop and ultimately test how well the CONNECT Multilingual (CONNECT ML) program works to improve smoking cessation among current ...
Smoking Cessation Interventions for Potential Use in the ...
We conducted a systematic review and meta-analysis of current literature on the efficacy of smoking cessation interventions among populations eligible for LCS.
Interventions Designed to Increase the Uptake of Lung ...
Interventions that were most effective in improving access to LCS targeted priority populations, raised community-level awareness, tailored materials for ...
Comparing Smoking Cessation Interventions among ...
The primary outcome is biochemically confirmed smoking abstinence sustained through 6 months. Secondary outcomes include abstinence sustained through 12 months, ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.